会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 63. 发明申请
    • METHOD FOR PRODUCING DENDRITIC CELLS
    • 生产细胞的方法
    • US20120040458A1
    • 2012-02-16
    • US13127753
    • 2009-11-13
    • Yoshikazu YonemitsuYasuji UedaYui Harada
    • Yoshikazu YonemitsuYasuji UedaYui Harada
    • C12N5/0784
    • C12N5/0639A61K39/00C12N2501/125C12N2501/145C12N2501/22C12N2501/23C12N2501/26
    • An objective of the present invention is to provide methods for producing dendritic cells (DCs), which comprise the step of culturing DC precursor cells in the presence of a plurality of cytokines, produced dendritic cells, and uses thereof.The present inventors discovered that dendritic cells with a high IL-12 productivity can be obtained by culturing DC precursor cells in the presence of a plurality of cytokines, followed by about one week of culture in the presence of GM-CSF and IL-4. The present invention enables preparation of a large amount of DCs with a high IL-12 productivity from a small number of DC precursor cells, and therefore makes it easier to increase the number of DCs for administration in DC-based anti-tumor immune therapy, treatment of infections, etc. Thus, the effect of DC vaccines is expected to be enhanced.
    • 本发明的目的是提供用于制备树突状细胞(DC)的方法,其包括在多种细胞因子,产生的树突状细胞的存在下培养DC前体细胞的步骤及其应用。 本发明人发现通过在多种细胞因子的存在下培养DC前体细胞,然后在GM-CSF和IL-4存在下培养约1周,可获得具有高IL-12生产能力的树突状细胞。 本发明能够从少量的DC前体细胞制备大量具有高IL-12生产能力的DC,因此可以更容易地增加DC-抗肿瘤免疫治疗中用于给药的DC数量, 治疗感染等。因此,预期DC疫苗的效果将得到提高。